Pfizer Signs Licensing Agreement With Starna Therapeutics Worth Up to $2.63 Billion
Pfizer announced it entered into a licensing agreement with Starna Therapeutics valued at up to USD 2.63 billion.
Pfizer announced it entered into a licensing agreement with Starna Therapeutics valued at up to USD 2.63 billion.